Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/14/2014US20140228387 Disubstituted 5-fluoro-pyrimidines
08/14/2014US20140228386 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS
08/14/2014US20140228385 Process for rilpivirine
08/14/2014US20140228383 Process for the production of moxonidine
08/14/2014US20140228379 Pyrido-Pyrimidine Derivatives
08/14/2014US20140228378 N-(Benzimimdazol-2-yl)-Cyclopropane Carboxamides as Lysophosphatidic Acid Antagonists
08/14/2014US20140228376 Heterocyclic Compounds for the Treatment of CF
08/14/2014US20140228375 Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anti-cancer activity
08/14/2014US20140228371 Quinoline and quinazoline amides as modulators of sodium channels
08/14/2014US20140228370 Substituted imidazopyridazines
08/14/2014US20140228366 Heteroaryl-substituted pyrazolopyridines and use thereof as soluble guanylate cyclase stimulators
08/14/2014US20140228364 Ophthalmic Compositions Comprising Prostaglandin F2 Alpha Derivatives and Hyaluronic Acid
08/14/2014US20140228363 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
08/14/2014US20140228361 Aminoquinazoline derivatives and their salts and methods of use
08/14/2014US20140228359 Bis-indolic derivatives, their uses in particular as antibacterials
08/14/2014US20140228355 Novel D3 Dopamine Receptor Agonists to Treat Dyskinesia in Parkinson's Disease
08/14/2014US20140228354 Method for Inhibition of Deubiquitinating Activity
08/14/2014US20140228353 Compounds and methods of treating diabetes
08/14/2014US20140228350 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
08/14/2014US20140228340 Benzonitrile derivatives as kinase inhibitors
08/14/2014US20140228337 Tazobactam Arginine Compositions
08/14/2014US20140228336 The use of 3-methoxy-pregnenolone for hte preparation of a drug for treating a traumatic brain inury
08/14/2014US20140228335 Ulipristal Acetate Tablets
08/14/2014US20140228333 Methods for inhibiting muscle atrophy
08/14/2014US20140228332 Method for enhancing the secretion of glp-1 using bitter compounds
08/14/2014US20140228331 Compositions of protein receptor tyrosine kinase inhibitors
08/14/2014US20140228330 Pharmaceutical compositions
08/14/2014US20140228329 Use of 25-hydroxy vitamin d3 to promote phosphorous utilisation in ruminants
08/14/2014US20140228327 Antimicrobial flush solutions
08/14/2014US20140228323 Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors
08/14/2014US20140228317 Modified Pectins, Compositions and Methods Related Thereto
08/14/2014US20140228316 PPS for the prevention of potential adverse effects caused by CD3 specific binding domains
08/14/2014US20140228315 Blockade of eosinophil production by toll-like receptors
08/14/2014US20140228314 METHOD FOR PREPARATION OF CHITOSAN OLiGOSACCHARIDES COMPOSITION AND MIXTURE OF CHITOSAN OLiGOSACCHARIDES PREPARED THEREFROM
08/14/2014US20140228313 Methods and compositions for preventing and treating a disease related to glycan dysregulation
08/14/2014US20140228312 Antibiotic composition and its uses
08/14/2014US20140228309 Stabilized formulation for oral administration of therapeutic agents and related methods
08/14/2014US20140228308 Formulations for the oral administration of therapeutic agents and related methods
08/14/2014US20140228307 Composition and method for treating an autoimmune disease
08/14/2014US20140228306 Phenolic Coatings and Methods of Making and Using Same
08/14/2014US20140228305 Method for utilizing extraction residue of yeast extract
08/14/2014US20140228304 Combined allergy treatment and anti-drying compositions and related methods
08/14/2014US20140228303 Novel sglt inhibitors
08/14/2014US20140228300 Methods for modulating factor 12 expression
08/14/2014US20140228296 Diagnosis, prognosis, and treatment of kidney disease
08/14/2014US20140228290 Compositions and methods of treating cancer
08/14/2014US20140228287 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-axanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal
08/14/2014US20140228286 Specific pde4b-inhibitors for the treatment of diabetes mellitus
08/14/2014US20140228283 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
08/14/2014US20140227375 PIP-2 Inhibition-Based Antiviral and Anti-Hyperlipidemic Therapies
08/14/2014US20140227374 Multifunctional topical formulation for the treatment of acne vulgaris and other skin conditions
08/14/2014US20140227371 Edible composition
08/14/2014US20140227367 Treating inflammation with a combination of an ellagitannin and hydrogen peroxide
08/14/2014US20140227366 Carrier material for improving the persistance of biocides
08/14/2014US20140227365 pH BUFFERED BIOACTIVE GLASS, AND ITS PREPARATION PROCESS AND USE
08/14/2014US20140227360 Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
08/14/2014US20140227358 Organic compounds
08/14/2014US20140227356 Composite formulation comprising a tablet encapsulated in a hard capsule
08/14/2014US20140227355 Pharmaceutical composition for oral administration with a statin
08/14/2014US20140227354 Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
08/14/2014US20140227353 Pharmaceutical compositions for the treatment of helicobacter pylori
08/14/2014US20140227351 Taste masked pharmaceutical composition
08/14/2014US20140227347 Methods of treatment of diseases
08/14/2014US20140227344 Cell Penetrating Peptides for Intracellular Delivery of Molecules
08/14/2014US20140227343 Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles
08/14/2014US20140227342 Acetylcholinesterase inhibitor composition for sexual use
08/14/2014US20140227341 Methods of using regenerative cells to promote wound healing
08/14/2014US20140227340 Fibers Comprising Poorly Soluble Drugs and/or Proteins
08/14/2014US20140227335 Virucidal small molecule and uses thereof
08/14/2014US20140227326 Method of delivering nasal spray
08/14/2014US20140227316 Beta-lactam compounds for enhancing t cell-mediated immune responses
08/14/2014US20140227302 Gamma secretase inhibitors
08/14/2014US20140227300 Inhibition of innate immune response
08/14/2014US20140227299 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
08/14/2014US20140227293 Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
08/14/2014US20140227288 Pnmt as a novel marker for progenitor cells
08/14/2014US20140227284 Synthetic lethality and the treatment of cancer
08/14/2014US20140227282 Therapeutic agent for pancreatic cancer and/or biliary tract cancer
08/14/2014US20140227281 Methods of Treating Herpesvirus Infections
08/14/2014US20140227278 Antibodies to human signal peptide-containing proteins
08/14/2014US20140227277 Combination therapy with an anti-CD19 antibody and a purine analog
08/14/2014US20140227276 Gpr177 as target and marker in tumors
08/14/2014US20140227272 Anti-Leukocyte Adhesion for the Mitigation of Potential Adverse Events caused by CD3-Specific Binding Domains
08/14/2014US20140227262 PD-1 Antagonists and Methods for Treating Infectious Disease
08/14/2014US20140227261 Use of omega fatty acids for treating disease
08/14/2014US20140227260 Aminopyrimidine inhibitors of tyrosine kinase
08/14/2014US20140227252 Methods and Monitoring of Treatment with a DLL4 Antagonist
08/14/2014US20140227243 Pharmaceutical compositions and related methods
08/14/2014US20140227242 Compositions containing non-polar compounds
08/14/2014US20140227239 Growth hormone secretagogue
08/14/2014US20140227234 Methods of using regenerative cells to promote wound healing
08/14/2014US20140227225 HCV Helicase Inhibitors and Methods of Use Thereof
08/14/2014US20140227224 Salts of hiv inhibitor compounds
08/14/2014US20140227222 Cyclin dependent kinase inhibitors and methods of use
08/14/2014US20140227221 Methods of treating multiple myeloma and resistant cancers
08/14/2014US20140227220 Method for treating chemotherpay-induced male infertility
08/14/2014US20140227218 Pharmaceutical Compositions of Conjugates Formed From Polymer Derivatives Having Particular Atom Arrangements
08/14/2014US20140227214 Protection Against Sunburn And Skin Problems With Topical And Orally-Ingested Dosages of Zeaxanthin
08/14/2014US20140227209 Methods For Treating Inflammatory Conditions
08/14/2014US20140227208 Cosmetic compositions containing substituted azole and methods for alleviating mechanically-induced skin inflammation
1 ... 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 ... 7860